Hims & Hers Health shares spike after group posts earnings beat, …
1 day ago · Hims&Hers is one such compounder, offering an injection of semaglutide -- the key ingredient in Novo Nordisk's popular Wegovy drug -- for $199 per month to patients on a 12-month plan, according ...
Hims Reports Strong Earnings, Novo Nordisk Copycat Drug …
5 hours ago · Hims' third-quarter results topped expectations, driven in part by revenue from its weight-loss drugs. The company said it plans to launch a generic version of a Novo Nordisk diabetes and weight ...
Hims Inc. - Hims & Hers Health, Inc. Reports Third Quarter 2024 ...
2 days ago · Revenue of $401.6 million, up 77% year-over-year in Q3 2024 Net income of $75.6 million; Adjusted EBITDA of $51.1 million in Q3 2024 Subscribers grew to 2.0 million, up 44% year-over-year in Q3 2024 Raises full year 2024 revenue guidance to a range of $1.460 billion to $1.465 billion and Adjusted EBITDA guidance to a range of $173 million to $178 million Hims Hers Health, Inc. (“Hims Hers ...
HIMS Stock Gains Following In Line Q3 Earnings, Gross Margin …
12 hours ago · Hims & Hers Health, Inc. HIMS delivered an earnings per share (EPS) of 32 cents in third-quarter 2024 against the year-ago period’s loss of 4 cents per share. The metric was in line with the ...
Hims & Hers up 7% on raised 2024 revenue guidance, Q3 beats
1 day ago · Hims & Hers was helped in the quarter by a dramatic 77% year-over-year increase in revenue to ~$401.6M. The company swung to net income of ~$76M from a loss of $7.4M in Q3 2023 ($0.32 per share ...
Hims & Hers shares rally on results, but execs say GLP-1
1 day ago · Earnings Results Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’ ‘In the last two months, a total of nearly 80,000 individuals reported through our ...
How We’re Making Personalized Healthcare the New Standard - news.hims…
2 days ago · Company News. How We’re Making Personalized Healthcare the New Standard . Written by. Andrew Dudum. November 4, 2024. We’re closer than ever to reaching our goal of every household in the US trusting Hims & Hers for their personalized health and wellness needs. ... In a survey of 920 Hims & Hers customers, early in their treatment ...
Hims & Hers Newsroom
Hims & Hers Expands into Cardiovascular Health with New Dual-Action Capabilities
Hims & Hers will start selling a generic weight loss drug
11 hours ago · The millennial-skewed telehealth platform Hims & Hers (HIMS+1.30%) announced Monday that it will start offering customers a generic version of liraglutide, an older GLP-1 weight loss drug, next ...
Hims & Hers Health: Another Blowout Quarter Ignored
11 hours ago · Hims produced Q3 free cash flow of $79 million and used roughly $30 million to repurchase 1.9 million shares at $15.83 per share. The company ended the quarter with a $251 million cash balance .